Wednesday, 25 May 2011

Ethyol




In the US, Ethyol (amifostine systemic) is a member of the drug class antineoplastic detoxifying agents and is used to treat Cancer, Non-Small Cell Lung Cancer and Ovarian Cancer.

US matches:

  • Ethyol

Ingredient matches for Ethyol



Amifostine

Amifostine is reported as an ingredient of Ethyol in the following countries:


  • Australia

  • Bahrain

  • Belgium

  • Brazil

  • Chile

  • Colombia

  • Costa Rica

  • Czech Republic

  • Dominican Republic

  • El Salvador

  • Finland

  • France

  • Germany

  • Guatemala

  • Honduras

  • Israel

  • Italy

  • Mexico

  • Netherlands

  • New Zealand

  • Nicaragua

  • Panama

  • Philippines

  • Portugal

  • Romania

  • Spain

  • Taiwan

  • Thailand

  • Turkey

  • United States

  • Venezuela

Amifostine trihydrate (a derivative of Amifostine) is reported as an ingredient of Ethyol in the following countries:


  • Greece

  • South Africa

International Drug Name Search

Monday, 23 May 2011

Flotral




Flotral may be available in the countries listed below.


Ingredient matches for Flotral



Alfuzosin

Alfuzosin is reported as an ingredient of Flotral in the following countries:


  • India

  • Peru

International Drug Name Search

Saturday, 21 May 2011

Menatriptan




Menatriptan may be available in the countries listed below.


Ingredient matches for Menatriptan



Frovatriptan

Frovatriptan is reported as an ingredient of Menatriptan in the following countries:


  • Costa Rica

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Faxiprol




Faxiprol may be available in the countries listed below.


Ingredient matches for Faxiprol



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Faxiprol in the following countries:


  • Slovakia

International Drug Name Search

Clinaram




Clinaram may be available in the countries listed below.


Ingredient matches for Clinaram



Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clinaram in the following countries:


  • Oman

International Drug Name Search

Friday, 20 May 2011

Mefinal




Mefinal may be available in the countries listed below.


Ingredient matches for Mefinal



Mefenamic Acid

Mefenamic Acid is reported as an ingredient of Mefinal in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 19 May 2011

Kinzalplus




Kinzalplus may be available in the countries listed below.


Ingredient matches for Kinzalplus



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Kinzalplus in the following countries:


  • Switzerland

Telmisartan

Telmisartan is reported as an ingredient of Kinzalplus in the following countries:


  • Switzerland

International Drug Name Search

Monday, 16 May 2011

Non-Flat




Non-Flat may be available in the countries listed below.


Ingredient matches for Non-Flat



Simeticone

Simeticone is reported as an ingredient of Non-Flat in the following countries:


  • Peru

International Drug Name Search

Thursday, 12 May 2011

Loperal




Loperal may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Loperal



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Loperal in the following countries:


  • France

International Drug Name Search

Monday, 9 May 2011

Hy-50




Hy-50 may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Hy-50



Hyaluronic Acid

Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Hy-50 in the following countries:


  • Australia

  • Finland

  • Italy

  • Netherlands

  • Norway

  • Sweden

  • United Kingdom

International Drug Name Search

Thursday, 5 May 2011

Dibrompropamidine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D08AC01,S01AX14

CAS registry number (Chemical Abstracts Service)

0000496-00-4

Chemical Formula

C17-H18-Br2-N4-O2

Molecular Weight

470

Therapeutic Category

Dermatological agent: Topical antiseptic

Chemical Name

Benzenecarboximidamide, 4,4'-[1,3-propanediylbis(oxy)]bis[3-bromo-

Foreign Names

  • Dibrompropamidinum (Latin)
  • Dibrompropamidin (German)
  • Dibrompropamidine (French)
  • Dibrompropamidina (Spanish)

Generic Names

  • Dibrompropamidine (OS: BAN)
  • Dibromopropamidine (IS)
  • M & B 1270 (IS: MayBaker)
  • Dibrompropamidine Isetionate (OS: BANM)
  • Dibromopropamidine Isethionate (IS)
  • Dibrompropamidine 2-hydroxyethanesulfonate (IS)
  • Dibromopropamidine Isetionate (PH: BP 2010)
  • Dibrompropamidine Diisetionate (PH: Ph. Eur. 6)
  • Dibrompropamidini diisetionas (PH: Ph. Eur. 6)

Brand Names

  • Antisep
    Sanofi-Aventis, Bangladesh


  • Brolene
    Genop Healthcare, South Africa; Sanofi-Aventis, Australia; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Ireland; Sanofi-Aventis, New Zealand


  • Brulidine
    Sanofi-Aventis, Norway


  • Golden Eye
    Typharm, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 3 May 2011

Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules


Pronunciation: brome-fen- EER-ah-meen/soo-doe-eh-FED-rin
Generic Name: Brompheniramine/Pseudoephedrine
Brand Name: Examples include Bromfenex and Histex SR


Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules are used for:

Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.


Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.


Do NOT use Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules if:


  • you are allergic to any ingredient in Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules

  • you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems

  • you take sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules:


Some medical conditions may interact with Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a fast, slow, or irregular heartbeat; heart blood vessel problems; or other heart problems

  • if you have a history of asthma; lung problems (eg, emphysema); adrenal gland problems (eg, adrenal gland tumor); high blood pressure; diabetes; stroke; glaucoma; a blockage of your stomach, bladder, or intestines; ulcers; trouble urinating; an enlarged prostate; seizures; or an overactive thyroid

Some MEDICINES MAY INTERACT with Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Beta-blockers (eg, propranolol), COMT inhibitors (eg, tolcapone), furazolidone, indomethacin, MAO inhibitors (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because side effects of Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules may be increased

  • Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased

  • Bromocriptine or hydantoins (eg, phenytoin) because side effects may be increased by Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules

  • Guanadrel, guanethidine, methyldopa, mecamylamine, or reserpine because effectiveness may be decreased by Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules

This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules:


Use Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules may be taken with or without food.

  • Swallow Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules whole. Do not break, crush, or chew before swallowing.

  • If you miss a dose of Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules.



Important safety information:


  • Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules may cause dizziness, drowsiness, or blurred vision. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules. Using Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Do not take diet or appetite control medicines while you are taking Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules without checking with your doctor.

  • Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules contains pseudoephedrine. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains pseudoephedrine. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Do NOT exceed the recommended dose or take Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules for longer than prescribed without checking with your doctor.

  • If your symptoms do not improve within 5 to 7 days or if they become worse, check with your doctor.

  • Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules. Use a sunscreen or protective clothing if you must be outside for a prolonged period.

  • If you are scheduled for allergy skin testing, do not take Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules for several days before the test because it may decrease your response to the skin tests.

  • Before you have any medical or dental treatments, emergency care, or surgery, tell the doctor or dentist that you are using Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules.

  • Use Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules with caution in the ELDERLY because they may be more sensitive to its effects.

  • Caution is advised when using Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules, discuss with your doctor the benefits and risks of using Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules during pregnancy. It is unknown if Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules are excreted in breast milk. Do not breast-feed while taking Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules.


Possible side effects of Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Brompheniramine/Pseudoephedrine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


Proper storage of Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules:

Store Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules out of the reach of children and away from pets.


General information:


  • If you have any questions about Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules, please talk with your doctor, pharmacist, or other health care provider.

  • Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Brompheniramine/Pseudoephedrine Controlled-Release and Sustained-Release Capsules. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Brompheniramine/Pseudoephedrine resources


  • Brompheniramine/Pseudoephedrine Side Effects (in more detail)
  • Brompheniramine/Pseudoephedrine Use in Pregnancy & Breastfeeding
  • Brompheniramine/Pseudoephedrine Drug Interactions
  • Brompheniramine/Pseudoephedrine Support Group
  • 6 Reviews for Brompheniramine/Pseudoephedrine - Add your own review/rating


Compare Brompheniramine/Pseudoephedrine with other medications


  • Hay Fever
  • Nasal Congestion